Lisa M. Jenkins, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 37, Room 2140
- Bethesda, MD 20892
- 240-760-7209
- jenkinsl@mail.nih.gov
RESEARCH SUMMARY
Dr. Jenkins obtained her Ph.D. in Biochemistry and Molecular Biology at the University of Georgia. She continued her research at the National Cancer Institute, applying mass spectrometry and biochemical methods to examine the regulation and functional consequences of p53 post-translational modification. Currently, Dr. Jenkins serves as Facility Manager for the Mass Spectrometry Section within the CCR Collaborative Protein Technology Resource. In this capability, she collaborates with CCR researchers by performing mass spectrometry experiments to further investigate critical biological questions.
Areas of Expertise
Lisa M. Jenkins, Ph.D.
Publications
Conserved protein Pir2ARS2 mediates gene repression through cryptic introns in lncRNAs
The RepID-CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation
Enrichment of Aurora B kinase at the inner kinetochore controls outer kinetochore assembly
Tissue Architectural Cues Drive Organ Targeting of Tumor Cells in Zebrafish
Inhibition of HIV Maturation via Selective Unfolding and Cross-Linking of Gag Polyprotein by a Mercaptobenzamide Acetylator
Biography
Lisa M. Jenkins, Ph.D.
Dr. Jenkins obtained her Ph.D. in Biochemistry and Molecular Biology at the University of Georgia. She continued her research at the National Cancer Institute, applying mass spectrometry and biochemical methods to examine the regulation and functional consequences of p53 post-translational modification. Currently, Dr. Jenkins serves as Facility Manager for the Mass Spectrometry Section within the CCR Collaborative Protein Technology Resource. In this capability, she collaborates with CCR researchers by performing mass spectrometry experiments to further investigate critical biological questions.